News
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Amid growing concerns over the safety of COVID-19 vaccines, a significant lawsuit against prominent figures in the pharmaceutical industry and public health has taken a dramatic turn. Three new ...
A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...
12h
Zacks Investment Research on MSNMRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric PatientsModerna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for COVID-19 ...
BRUSSELS -- European Commission President Ursula von der Leyen comfortably survived a vote of no confidence on Thursday as an ...
23hOpinion
MedPage Today on MSNFDA Didn't Really Give 'Full Approval' to Moderna's Pediatric COVID VaccineHow did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...
US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...
More than 70 far-right MEPs, including Luxembourg’s Fernand Kartheiser, had tabled motion against European Commission head ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
European Commission President Ursula von der Leyen comfortably survived a vote of no confidence on Thursday, as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results